Skip to main content
International Journal of Surgery Case Reports logoLink to International Journal of Surgery Case Reports
. 2013 Nov 14;5(1):8–11. doi: 10.1016/j.ijscr.2013.10.013

An unusual case of primary colonic dedifferentiated liposarcoma

Mehmet Akif Türkoğlu a,, Gülsüm Özlem Elpek b, Volkan Doğru a, Hasan Çalış c, Aslı Uçar b, Cumhur Arıcı a
PMCID: PMC3907200  PMID: 24394854

Abstract

INTRODUCTION

İn this paper, we present a rare case of primary dedifferantiated liposarcoma (DDLS) of the colon, management of which is unclear and difficult to cope with.

PRESENTATION OF CASE

71 year old female patient with complaints of abdominal pain and swelling was referred to our clinic with the diagnosis of intraabdominal mass. 23 cm × 19 cm × 18 cm tumor starting from the neighborhood of left liver lobe and extending toward pelvic floor was detected on computed tomography. At laparotomy, a multilobulated, soft and yellowish mass was arising from transvers colon and invading greater curvature of stomach. En-bloc removal of the tumor including segmental colon and gastric wedge resection was performed. Postoperative histopathological diagnosis was consistent with dedifferentiated liposarcoma.

DISCUSSION

Liposarcomas are rarely encountered in the gastrointestinal tract. Previously, only ten cases of primary liposarcoma of the colon have been reported worldwide and to our knowledge DDLS of transverse colon is the first case reported in the literature. DDLS is a high-grade aggressive tumor carrying the ability to metastasize. Despite complete removal of tumor recurrence is common in DDLS.

CONCLUSION

The constellation of findings in our patient demonstrates that liposarcomas which histologically exhibit dedifferentiation are associated with a poor clinical prognosis and advocating surgery alone is not recommended.

Keywords: Colonic dedifferantiated liposarcoma, Intraabdominal mass, Dedifferentiation

1. Introduction

Liposarcoma is one of the most common types of soft tissue tumors in adults. The incidence of liposarcoma peaks between 40 and 60 years.1 Liposarcomas are usually reported in the extremities and retroperitoneum whereas it has been rarely seen in the gastrointestinal tract, and colon is extremely uncommon site.2,3 Here, a case of DDLS which arising from transverse colon is presented, and the literature is reviewed.

2. Presentation of case

71 year old female patient was admitted to outside hospital with complaints of abdominal pain and swelling lasting for three months was referred to our clinic with the diagnosis of intraabdominal mass. There was no change in bowel movements, no sign for bowel obstruction and no weight loss. Triphasic computed tomography (CT) revealed a large macrolobulated peripherally enhancing mass compatible with gastrointestinal stromal tumor, approximately 23 cm × 19 cm × 18 cm in size starting from the neighborhood of left liver lobe and extending toward pelvic floor (Fig. 1). While not invading main vascular structures it was occupying most of the area adjacent to bowel loops and the tumor was invading gastric wall in a small portion at the greater curvature. There was no radiologic hint of colonic invasion or obstruction reported. Patient had a notably distended abdomen on physical examination. Tumor markers were normal. These findings were accepted as sufficient for preoperative diagnosis and no additional investigation was performed in order not to delay surgery. Since neoadjuvant therapy has been found to be inefficacious in such cases, patient was booked for operation. At laparotomy, a multilobulated, soft and yellowish mass approximately 25 cm × 18 cm × 18 cm in size was encountered (Fig. 2). It was arising from transvers colon and invading greater curvature of stomach. After a thorough exploration of abdominal cavity neither peritoneal implants nor ascites was noticed. The mass underwent en-bloc resection including segmental colon and gastric wedge resection. Patient was discharged on day 7 without any complications.

Fig. 1.

Fig. 1

Axial computed tomography scan shows irregularly mass which is occupying most of the abdomen.

Fig. 2.

Fig. 2

Intraoperative images of the tumor. (Arrow:Transverse colon).

The cut section showed a large grayish yellow nodular mass with few mucoid areas, along with a variegated appearance. At places, it appeared to be fleshy with focal areas of hemorrhage and necrosis (Fig. 3). The tumor center was located in the colon wall and invasion to stomach was minimal. Thus macroscopic image had a significant role in identifying the primary origin of the tumor which was accepted as colon. On microscopic examination there were areas with fibrosarcomatous, myxofibrosarcomatous, hemangioperistomatous, gastrointestinal stromal tumor like appearance adjacent to a lipogenic component that was composed of fat cells of varying sizes, which were separated by slender connective tissue septae. In these areas the neoplastic cells were uni or multivacuolated (lipoblasts) with moderately pleomorphic hyperchromatic nuclei, with a multivacuolated, clear cytoplasm (Fig. 4). Immunohistochemical staining revealed that tumor cells were positive with vimentin, CDK4 and S-100. EMA, C-kit, CD34, CD31, CD1A, SMA, S-100, NF, GFAP, HMB-45, NSE, ALK, CD99, BCL-2, Caldesmon, β-cathenin, myosin, desmin and FXIII was negative. On basis of these findings, the histopathological diagnosis was consistent with dedifferentiated liposarcoma.

Fig. 3.

Fig. 3

(a) Tumor mass located in the bowel wall beneath the mucosa (asterisk) and (b) the cut section of the tumor showing hemorrhage and necrosis.

Fig. 4.

Fig. 4

Fibrosarcoma (a) hemangioperistoma (b) and myxofibrosarcoma (c) like areas. Proliferation of atypical spindle or stellate cells supported by rich arborizing vasculature on the background of rich ground substance (d) with rare lipoblasts. (e) Nuclear CDK4 positive tumor cells.

Postoperative adjuvant radiotherapy was planned but patient voluntarily refused the treatment. Two months later, follow up CT studies revealed multiple peritoneal implants; 6 cm × 5 cm at most. The tumor followed an aggressive course with widespread metastatic disease and patient died within about 3 months of operation.

3. Discussion

Liposarcoma is the most common type of soft tissue sarcomas. About 24% of liposarcomas originate from limbs and 45% originate from retroperitoneal area.2 However liposarcomas are rarely encountered in the gastrointestinal tract.3–12

Liposarcomas have five histological subtypes; well-differentiated liposarcoma (WDLS), dedifferentiated liposarcoma (DDLS), pleomorphic, myxoid and round cell liposarcoma.13,14 Liposarcomas originating from the colon are very rare.3 Previously, only ten cases of primary liposarcoma of the colon have been reported worldwide but these reports were focusing on other locations of the colon and most histological subtypes were different from our case (Table 1).3–12 Also to our knowledge DDLS of transverse colon is the first case reported in literature.

Table 1.

Reported characteristics of cases of colonic liposarcoma.

Age-gender Size (cm)/location Histological subtype
Wood and Morgenstern 62-F 12/ileocecal valve Myxoid
Parks et al. 54-E 6/ascending colon Pleomorphic
Magro et al. 65-F 5/caecum Well-differentiated
Chen 52-F 7.5/descending colon Well-differentiated
Gutsu et al. 46-M 12/ascending colon Myxoid
Shahidzadeh et al. 56-F 3.5/hepatic flexure Well-differentiated
Chaudhary et al. 66-F 4.5/descending colon Well-differentiated
Jarboui et al. 69-M 7/splenic flexure Dedifferentiated
D’Annibale et al. 79-F 5.2/hepatic flexure Pleomorphic
Choi et al. 41-E 20/ascending colon Myxoid
Our case 71-K 23/transverse colon Dedifferentiated

Since DDLS is a high-grade sarcoma that originates in a background of a preexisting well-differentiated liposarcoma, it is considered a variant of well-differentiated liposarcoma.15 Histological subtype of the tumor is very important during the course of the disease. While dedifferentiated, round-cell and pleomorphic liposarcomas are high-grade aggressive tumors carrying the ability to metastasize, well-differentiated and myxoid liposarcomas are low-grade tumors and progressing more slowly.2,16

DDLS is often observed at sixth decade of life. It is more common in males and often exhibit abdominal cavity involvement.15 The most common abdominal involvement is retroperitoneum. However, intraperitoneal origin is extremely rare.2,12,17

DDLS may occur when well-differentiated liposarcoma transforms into non-lipogenic sarcoma areas. Dedifferentiation develops in 20% of the first local recurrence and 44% of the second local recurrence, and this has been shown to be related to poor progression and metastasis.16

When DDLS develops inside the abdominal cavity it presents with a space occupying mass lesion. The pathognomonic finding in computed tomography (CT) and magnetic resonance imaging is a heterogeneous and nonlipogenic encapsulated mass.18 These findings are sufficient for the diagnosis and needle biopsy is not necessary.

Surgery is the best method of treatment for dedifferentiated liposarcomas. DDLS sometimes invade adjacent structures. In such cases, when safe dissection plan can not be obtained, en bloc resection can be done. It is important to remove tumor entirely.3–12 In cases where total resection can not be achieved, debulking surgery has not been demonstrated to contribute to the overall disease-free survival rates. The targeted chemotherapeutic agents and radiation therapy are being investigated for these unresectable cases.19 In our case, en-bloc resection including colon segmental and gastric wedge resection was performed to the mass arising from transverse colon invading gastric greater curvature.

Even though tumor size, histologic subtype, dissemination are important prognostic factors, it is still difficult to predict prognosis of colonic liposarcoma.12 As in our case, liposarcomas which histologically demonstrate dedifferentiation are associated with a poor clinical prognosis.20

Recurrence is common in liposarcomas. There are studies recommending chemotherapy as the initial course of action in DDLS exhibiting local recurrence where tumor growing faster than 1 cm/month in CT imaging.13 Neoadjuvant therapy has not demonstrated clinical benefit.21,22 Therefore, neoadjuvant therapy was abandoned in our case considering that it does not provide an additive affect on overall disease-free survival rates. There are studies favoring adjuvant radiotherapy in maintenance of local control.23

4. Conclusion

In DDLS, local recurrence, distant metastasis, and disease-related mortality rates are 52%, 15% and 30%, respectively.15 In general, it should be kept in mind that DDLS follows a dreadful course in terms of treatment and prognosis as the tumor exhibits rapid progression characteristics despite chemoradiotherapy. Surgery is still the most effective treatment option, but relying on this approach alone is not sufficient for disease-free survival.

Conflict of interest statement

None.

Funding

None.

Ethical approval

Written informed consent was obtained from the patient's relatives for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Author contributions

Mehmet Akif Türkoğlu contributed to study design, data collections, data analysis, writing. Gülsüm Özlem Elpek contributed to writing. Volkan Doğru contributed to writing. Hasan Çalış contributed to data collections, data analysis, writing. Aslı Uçar contributed to data analysis. Cumhur Arıcı contributed to data analysis.

Footnotes

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  • 1.Yuri T., Miyaso T., Kitade H., Takasu K., Shikata N., Takada H. Well-differentiated liposarcoma, an atypical lipomatous tumor, of the mesentery: a case report and review of the literature. Case Rep Oncol. 2011;4(1):178–185. doi: 10.1159/000327266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Singer S., Antonescu C.R., Riedel E., Brennan M.F. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358–370. doi: 10.1097/01.sla.0000086542.11899.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Choi Y.Y., Kim Y.J. Jin SY Primary liposarcoma of the ascending colon: a rare case of mixed type presenting as hemoperitoneum combined with other type of retroperitoneal liposarcoma. BMC Cancer. 2010;10:239. doi: 10.1186/1471-2407-10-239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wood D.L., Morgenstern L. Liposarcoma of the ileocecal valve: a case report. Mt Sinai J Med. 1989;56:62–64. [PubMed] [Google Scholar]
  • 5.Parks R.W., Mullan F.J., Kamel H.M.H., Walsh M.Y., McKelvey S.T. Liposarcoma of the colon. Ulster Med J. 1994;63:111–113. [PMC free article] [PubMed] [Google Scholar]
  • 6.Magro G., Gurrera A., Di Cataldo A., Licata A., Vasquez Well differentiated lipoma like liposarcoma of the caecum. Histopathology. 2000;36(4):380–387. doi: 10.1046/j.1365-2559.2000.0855d.x. [DOI] [PubMed] [Google Scholar]
  • 7.Chen K.T. Liposarcoma of the colon: a case report. Int J Surg Pathol. 2004;12:281–285. doi: 10.1177/106689690401200312. [DOI] [PubMed] [Google Scholar]
  • 8.Gutsu E., Ghidirim G., Gagauz I., Mishin I., Iakovleva I. Liposarcoma of the colon: a case report and review of the literature. J Gastrointest Surg. 2006;10(5):652–656. doi: 10.1016/j.gassur.2005.09.014. [DOI] [PubMed] [Google Scholar]
  • 9.Chaudhary A., Arora R., Sharma A., Aggarwal S., Safaya R., Sharma S. Primary colonic liposarcoma causing colo-colic Intusussception: a case report and review of literature. Gastrointest Cancer. 2007;38(2-4):160–163. doi: 10.1007/s12029-008-9031-1. [DOI] [PubMed] [Google Scholar]
  • 10.Shahidzadeh R., Ponce C.R., Lee J.R., Chamberlain S.M. Liposarcoma in a colonic polyp: case report and review of the literature. Dig Dis Sci. 2007;52:3377–3380. doi: 10.1007/s10620-007-9806-4. [DOI] [PubMed] [Google Scholar]
  • 11.Jarboui S., Moussi A., Jarraya H., Ben Mna K., Abdesselem M.M., Kourda A. Primary dedifferentiated liposarcoma of the colon: a case report. Gastroenterol Clin Biol. 2009;33(10-11):1016–1018. doi: 10.1016/j.gcb.2008.11.014. [DOI] [PubMed] [Google Scholar]
  • 12.Marco D’Annibale, Maurizio Cosimelli, Renato Covello Elisa Stasi Liposarcoma of the colon presenting as an endoluminal mass World. J Surg Oncol. 2009;7:78. doi: 10.1186/1477-7819-7-78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Crago A.M., Singer S. Clinical lar approaches to well differentiated and dedifferentiated liposarcoma. Curr Opin Oncol mol. 2011;(4):373–378. doi: 10.1097/CCO.0b013e32834796e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fletcher C.D. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology. 2006;48(1):3–12. doi: 10.1111/j.1365-2559.2005.02284.x. [DOI] [PubMed] [Google Scholar]
  • 15.Nascimento A.G. Dedifferentiated liposarcoma. Semin Diagn Pathol. 2001;18(4):263–266. [PubMed] [Google Scholar]
  • 16.Dalal K.M., Kattan M.W., Antonescu C.R., Brennan M.F., Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381–391. doi: 10.1097/01.sla.0000234795.98607.00. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Goel A.K., Sinha S., Kumar A., Karak A.K., Chattopadhyay T.K. Liposarcoma of the mesocolon – case report of a rare lesion. Surg Today. 1994;24:1003–1006. doi: 10.1007/BF02215814. [DOI] [PubMed] [Google Scholar]
  • 18.Murphey M.D., Arcara L.K., Fanburg-Smith J. From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation. Radiographics. 2005;25:1371–1395. doi: 10.1148/rg.255055106. [DOI] [PubMed] [Google Scholar]
  • 19.Bonvalot S., Miceli R., Berselli M., Causeret S., Colombo C., Mariani L. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–1514. doi: 10.1245/s10434-010-1057-5. [DOI] [PubMed] [Google Scholar]
  • 20.Reitan J.B., Kaalhus O., Brennhovd I.O., Sager E.M., Stenwig A.E., Talle K. Prognostic factors in liposarcoma. Cancer. 1995;55:2482–2490. doi: 10.1002/1097-0142(19850515)55:10<2482::aid-cncr2820551029>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  • 21.Rosai J., Akerman M., Dal Cin P., DeWever I., Fletcher C.D., Mandahl N. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group) Am J Surg Pathol. 1996;20:1182–1189. doi: 10.1097/00000478-199610000-00002. [DOI] [PubMed] [Google Scholar]
  • 22.Eilber F.C., Eilber F.R., Eckardt J., Rosen G., Riedel E., Maki R.G. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg. 2004;240:686–695. doi: 10.1097/01.sla.0000141710.74073.0d. discussion 695–687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pawlik T.M., Pisters P.W., Mikula L., Feig B.W., Hunt K.K., Cormier J.N. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006 doi: 10.1245/ASO.2006.05.035. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Surgery Case Reports are provided here courtesy of Wolters Kluwer Health

RESOURCES